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ABSTRACT 
COMPARISON OF LONGITUDINAL CHANGES IN RESTING STATE 
FUNCTIONAL MAGNETIC RESONANCE IMAGING BETWEEN 
ALZHEIMER’S PATIENTS AND HEALTHY CONTROLS 
 
by 
Berk Can Yilmaz 
Resting State Functional Magnetic Resonance Imaging (rs-fMRI) is a technique that is 
widely used for analyzing brain function using different approaches and methods. This 
study involves rs-fMRI analysis of Blood Oxygenation Level Dependent (BOLD) 
signals acquired from Alzheimer’s disease (AD) Patients and Healthy Controls (HC). 
Each subject in the study had both functional and anatomical images with at least one 
rs-fMRI scan with their Anatomical (T1) scans. Previous rs-fMRI studies have 
demonstrated that AD shows differences in Amplitude of Low Frequency (<0.1 Hz) 
Fluctuations (ALFF), and Regional Homogeneity (ReHo) measures according to HCs.  
 The aim of the study is to investigate individual and group level differences 
using ReHo and mALFF related measures in a longitudinal analysis. The hypothesis is 
that with the age and group (AD or HC) of the subject, it is possible to separate AD and 
HC subjects from each other using 3 different ROIs (DMN – MT – MV), These regions 
are known to show abnormalities in AD patients but clinical wise never been identified 
as neuroimaging biomarkers. This study tries to check these ROIs to see if there are 
significant differences between the AD patients and HCs using 3 different features.
COMPARISON OF LONGITUDINAL CHANGES IN RESTING STATE 
FUNCTIONAL MAGNETIC RESONANCE IMAGING BETWEEN 
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1.1 Alzheimer’s Disease 
This current study focuses on functional brain activity in Alzheimer’s disease (AD) patients 
and compares against healthy control subjects. AD, discovered and named after German 
psychiatrist Dr. Alois Alzheimer, is a progressive neurodegenerative disease that affects older 
people (>50 years old). His patient, Auguste D., experienced memory loss, paranoia, 
psychological changes, and cognitive impairment. During the autopsy, Dr. Alzheimer found 
abnormalities in the white matter (WM) of the AD patient’s brain (Azeez & Biswal, 2017, 
Hippius & Neundörfer, 2003, Giffard et al., 2008). Figure 1 presents a representation of the 
known risk factors associated with AD. 
 





AD patients experience psychiatric symptoms and dementia that gradually progress with age 
(Onyike, 2017), as represented in Figure 1.2. A recent study by Xia-a Bi and colleagues showed 
that the number of AD patients worldwide could potentially reach one hundred million by 2050 
(Bi et al., 2018). This necessitates the importance of having an early detection mechanism. 
Biomarkers in neuroimaging provide the opportunity to improve early detection by identifying 
changes that occur with the progression of psychiatric symptoms and dementia (Onyike, 2017). 
For AD specifically, early detection can be improved by identifying changes in cognitive 
function with neuroimaging. 
 
 
Figure 1.2 Natural history of Alzheimer’s disease. Adapted from Feldman and Gracon, 1996. 
 
Using neuroimaging to compare differences in cognitive function between AD patients and 
healthy individuals provides the opportunity to better understand the progression of the disease. 
Neuroimaging for AD also provides the opportunity to improve early detection based on 







Figure 1.3 Three stage progress of Alzheimer’s disease. 
 
Currently, various methods in neuroimaging are being used for the detection of AD. Positron 
emission tomography (PET), magnetic resonance imaging (MRI), and functional MRI (fMRI) 
are common neuroimaging methods that have been widely used to study AD. PET is a 
neuroimaging method used for detecting changes in metabolic activity in the brain. The 
disadvantages of the PET technique include its use of radioactive substances and its low spatial 
and temporal resolution. 
MRI is a neuroimaging method used to generate images of organs in the body. MRI 
uses protons and electromagnetic waves to obtain images with high spatial resolution. MRI 
does not have any known side effects and is therefore widely used in clinical imaging. The 
fMRI method is a dynamic version of MRI and is widely used to study human brain function. 
Some of the advantages of fMRI include the use of non-ionizing radiation, the ability to be non-





and temporal resolution (Bi et al., 2018, Tepmongkol et al., 2019, Giffard et al., 2008, Li et al., 
2002). 
          Resting-state functional magnetic resonance imaging (rs-fMRI) is becoming more popular 
in the field of neuroimaging. For patients with AD, rs-fMRI is emerging as a standardized 
method which allows for the measurement of functional connectivity in the brain. The use of 
rs-fMRI suggests that data or model-driven methods can enable researchers to discern the 
decline of brain function. More information regarding fMRI is discussed in Chapter 2.  
 
1.2 Biomarkers 
Biomarkers, first created for chronic pain disorders, are measurable parameters that can be used 
to reliably identify disorders. Examples of biomarkers used today include prognostic and 
predictive markers which, as the name suggests, can determine the risk of future pain and 
ascertain the effects of treatment (van der Miesen et al., 2019, Woo & Wagner, 2015). 
Neuroimaging biomarkers have certain features that can classify biomarkers as functional or 
not. In the field of AD, technological advances have been made in identifying biomarkers by 
using neuroimaging approaches to recognize changes that are associated with the progression 
of the disease, especially in the frontal gyrus (FG) and the default mode network (DMN). In 
AD patients, functional connectivity between the FG and other brain regions appear abnormal, 
which may explain memory dysfunction and allow FG to be a potential biomarker for AD (Bi 
et al., 2018). Suitable biomarkers must provide reliable information about the condition of the 
living organism, and effective biomarkers are those that can allow us to better understand a 
condition. This means that a biomarker should have distinguishable parameter(s) that are able 
to identify significant differences and distinct conditions.  A quality biomarker should offer 





accomplished based on the sensitivity of the technique (Damoiseaux, 2012, Woo et al., 2017, 
Woo & Wagner, 2015).  
 
1.3 Objectives 
The objective of this study is to see if the progression of Alzheimer‘s disease can be explained 
by applying a multiple linear regression analysis using the information from ReHo and RSFC 
spatial maps, and determine if this information can be used for early detection for this disease. 
Altered brain regions in AD patients were determined by using several complimentary 
approaches such as independent component analysis (ICA), regional homogeneity (ReHo), and 
amplitude of low-frequency fluctuations (ALFF). Spatial maps, generated from rs-fMRI scans 
of AD patients and HCs and analyzed using a multiple linear regression analysis, are to be used 
to compare the two groups in a longitudinal approach. In this study, three regions were selected 
to be used in multiple analysis techniques using age and condition (HC or AD) to separate the 
two groups and identify the progression of the disease. Chapter 4 explains the various analysis 
methods used for this study in more detail.  
 
1.4 Outline 
The outline of this thesis is presented as follows: Chapter 1 – Introduction, Chapter 2 – Magnetic 
Resonance Imaging and Data Acquisition, Chapter 3 – Image Processing Methods, Chapter 4 












MAGNETIC RESONANCE IMAGE SCANNING AND DATA ACQUISITION 
 
2.1 Magnetic Resonance Imaging Techniques 
2.1.1 Magnetic Resonance Imaging Review 
Magnetic Resonance Imaging (MRI) uses large magnetic fields with radiofrequency signals in 
conjunction with hydrogen protons in our body to create high resolution structural images of 
soft tissue. MRI has been used to study structural brain differences between healthy controls 
and diseased patients, such as AD patients. fMRI has been used during both stimulus/task 
activation and during the resting state condition to study systems-level human brain function. 
In this section, MRI and functional MRI will be introduced to provide a background for the 
techniques used in this study.  
MRI uses strong magnetic fields in conjunction with radiofrequency signals at preset 
frequencies (Larmor Frequency) to generate images. The generated magnetic field strengths are 
typically represented in tesla (T), where one tesla equals 10,000 gausses. Although 3T machines 
are widely used for human research, there are also 1.5T, 7T, and 11T MRI scanners available. 
An MRI scanner has three main components, each represented by a letter in the MRI acronym. 
The letter M in MRI stands for magnetic fields, which are typically generated by 
superconducting coils within the machine. The magnetic field is responsible for stimulating 
hydrogen protons or spin vectors. Stimulated spin vectors all align in the same direction of the 
magnetic field. The letter R in MRI stands for resonance, which is the delivery of radio 
frequencies (RF) at the Larmor frequency. The Larmor frequency is the frequency value needed 
to stimulate aligned spin vectors in a given region. In other words, the Larmor frequency is the 
frequency value of the atomic nuclei for a hydrogen atom at a particular magnetic amplitude. 





of the magnetic field strength over space. This can be done by turning the coils on and off. 
Acquired signals are used within Discrete Signal Processing (DSP) cards to reconstruct the 
incoming signals from the X – Y – Z planes to create a 3D image of the target tissue that is 
being scanned (Huettel et al., 2014). 
MRI scanners use pulse sequences to control the timing of signal excitation and data 
collection and to generate images from biological tissues. The pulse sequence is a feature that 
allows an MRI scanner to acquire images with distinct timing to highlight different tissues with 
different physical properties. By using different pulse sequences, it is possible to create images 
of different biological tissues (bones, tumors, muscles). However, MRI has several limitations, 
such as difficulties in scanning patients with claustrophobia, obesity, and/or metal implants 
(Huettel et al., 2014). In spite of these limitations, MRI is routinely used for clinical imaging 
and remains one of the most popular methods for performing structural imaging.  
T1 and T2 relaxation times are used as a means of generating images for brain mapping. 
T1 relaxation is used for anatomical images and is the most common technique used to generate 
3D structural images of the brain. Anatomical images are also known to be called T1 images if 
T1 relaxation is used during generation. T1 relaxation, or T1 recovery time, is the amount of 
time spent for a spin vector to get its maximum longitudinal magnetization value after an RF 
pulse. In other words, the T1 recovery graph is the longitudinal magnetization value as a 
function of time after an RF pulse.  
T2 or T2 decay graphs are generated similarly. However, T2 uses the transverse 
magnetization value as a function of time. Another value that is important in T2 decay graphs 
is T2*. T2* is the decaying sinusoidal signal used in fMRI. Using the T2-weighted MRI 
technique, manipulations in blood oxygen can be measured (Ogawa et al., 1990). The gradient 
echo approach is often used with different variations to make tissues sensitive to T2* contrast. 





summary, the T2* principle is the foundation for a BOLD contrast. It is the main reason that 
fMRI has a high temporal resolution (Huettel et al., 2014).   
 
2.1.2 Functional Magnetic Resonance Imaging Review 
The term fMRI, as the name implies, allows us to investigate human brain function for a short 
time period. The data is typically sampled every 2 seconds, referred as the repetition time (TR). 
fMRI has a high temporal resolution that can measure short-term functional activity changes, 
allowing researchers to localize brain activity on a second-by-second basis. Since fMRI also 
has high spatial resolution capabilities, fMRI is a powerful tool to investigate brain activity. 
Unlike PET, fMRI does not use radiation or isotopes and is non-invasive, allowing patients to 
be scanned multiple times. These features are the main reason that made fMRI a popular 
investigative tool. Currently, fMRI is one of the most essential and standard investigative 
neuroimaging tools that many researchers prefer to use. 
fMRI uses Blood Oxygen Level Dependent (BOLD) signal changes to measure 
functional activity (Huettel et al., 2014). The blood oxygen level dependent (BOLD) signal, 
which is detected with fMRI, shows the changes in deoxyhemoglobin with localized changes 
of brain blood flow and blood oxygenation. This shows the underlying neuronal activity by 
presuming more oxygen will be used in more active parts of the brain in a mechanism known 
as neuro-coupling. There are mainly two kinds of fMRI techniques that are performed: task-
based fMRI (task-fMRI) and resting-state fMRI (rs-fMRI). As the name suggests, task-based 
fMRI uses various tasks during the scanning procedure. In task-based studies, a stimulus/task 
is presented for a short period of time alternating with periods of control conditions. It is 
currently believed that when a subject performs or responds to a task, there is an increase in 
neuronal firing in specific regions of the brain. These increased neuronal firings result in an 





results in more oxygenated red blood cells than is needed, and the difference between 
oxygenated red blood cells and deoxygenated red blood cells results in signal increases in 
regions associated with the task. On the other hand, rs-fMRI checks for functional activity in 
the brain while the subject is resting. In other words, no specific task scans are acquired in rs-
fMRI, and the subjects are simply instructed to rest (Huettel et al., 2014, Purves et al, 2011, 
Heeger & Ress, 2002). 
In terms of rs-fMRI, functional connectivity refers to the synchronization of brain 
regions that can form resting-state networks. In other words, functional connectivity is the 
common activity of spatially separated regions of the brain. These regions that have common 
or synchronized activity create resting state networks such as Default Mode Network, Medical 
Visual, Medial Temporal, etc. With this technique, it is possible to identify linked locations 
within the brain without the need for a physical connection between the brain regions. Usually, 
fMRI images have a 3 mm spatial resolution. This value is lower than T1 images. Furthermore, 
fMRI images are overlaid on the T1 images to help with the identification of brain regions in 
terms of structure (Lee et al., 2013).  
          Although MRI and fMRI both use the same principles and the same scanner, they are not 
the same. The main difference between fMRI and MRI for neuroimaging is that fMRI provides 
information about functional activity in the brain as a function of time. In contrast, MRI 
provides structural information about the brain. In other words, MRI scans provide anatomical 
scans of the brain, while fMRI scans provide information on the metabolic function of the brain 
(Huettel et al., 2014). Furthermore, fMRI provides functional information about the brain as 
well as how, when, and where a particular brain function occurred. It can also link various brain 







2.1.3 Blood Oxygen Level Dependent (BOLD) Signals 
Increased metabolic activity in a brain region, as reflected in an fMRI scan, implies that neurons 
in that region are active. Active neurons use more energy to be able to do their work, and more 
energy means more oxygen consumption. For neurons to be able to consume more oxygen for 
energy, there needs to be more oxygen in the area. Therefore, the need for oxygen to be used 
for energy affects neighboring blood vessels in the region to create increased oxygenated blood 
flow to that region. In summary, when there is increased metabolic activity at a brain region, 
the amount of blood flow increases as a result of glucose breakdown (Ogawa et al., 1990, Biswal 
et al., 1997, Huettel et al., 2014). 
Deoxygenated blood is visible with gradient-echo imaging. Gradient echo imaging uses 
free induction decay (FID) signals. FID is a short-lived sinusoidal signal that comes from the 
spin vectors after a 90-degree radiofrequency pulse. Every tissue characteristic of the FID signal 
will be different; thus, the incoming signal will be different. Differences in FID signals allow 
for the separation of different tissue types from each other. In summary, deoxygenated blood is 
a natural contrast that can be visualized with gradient-echo imaging using MRI. The concept 
used in FID signals also led to the creation of the concept of the BOLD signal (Ogawa et al., 
1990, Huettel et al., 2014). The BOLD signal is a metabolic signal, and changes in the ratio of 
oxyhemoglobin to deoxyhemoglobin are measured and can be linked to changes in neural 
activity (Azeez, 2019, Ogawa et al., 1990).  
The response of a neuron is much faster than the BOLD signal itself. Although 
indirectly, the BOLD signal response effect is from the firing of nerve cells. The hemodynamic 
response function (HRF) explains the changes in cerebral blood flow, oxygenation, and volume. 
BOLD signals are defined using HRF with fMRI. In other words, oxygenated blood gets 
converted to deoxygenated blood. Moreover, when neurons become active (when neuronal 





This process leads to a high-intensity response from the location of the scanned area that can 
be seen with fMRI (Ogawa et al., 1990, Boynton et al., 1996, Cohen, 1997). 
BOLD signal contrast depends on the amount of blood with deoxygenated hemoglobin, 
which will consume the present oxygen, within the brain region. The changes that happen in 
the BOLD signal are called HRF, and the fMRI modality is based on that principle. The BOLD 
signal can be seen with task-based fMRI research. Task-based fMRI (task-fMRI) is where 
subjects perform specific tasks during the fMRI scan, like finger tapping. Resting-State fMRI 
(rs-fMRI) checks for neurologic processes that occur without the need for tasks and, unlike 
task-fMRI, does not limit the experimental design or the number of questions that can be 
answered with the technique (Azeez, 2019, Huettel et al., 2014).  
Furthermore, fMRI has a high temporal resolution, which is around 500 milliseconds to 
3000 milliseconds (ms). Generally, a stimulus takes about 10 seconds, enough to able to see the 
neuronal activation as a function of HRF. A temporal resolution of 500 to 3000 ms (TR value) 
is good enough to answer most research questions. In resting state, frequency characteristics of 
neuronal activity within the BOLD signal can be seen under 0.1 Hz. However, the BOLD signal 
has components both above and below 0.1 Hz. The effects of respiratory and cardiac response 
on the BOLD signal can be seen in frequency values higher than 0.1 Hz. Generally, the 
elimination of these non-neuronal effects from the BOLD signal in rs-fMRI studies is needed. 
Therefore, band pass filtering is typically used. Generally, the low cutoff frequency equals to 
0.01 Hz (to eliminate small frequency noise from various sources) and the high cutoff frequency 
value is 0.1 Hz, as mentioned earlier (Biswal et al., 1995, Glover, 2011). The reduction of noise 
and removal of non-neuronal signals in this study will be explained in more detail within 







2.1.4 Application of Functional Magnetic Resonance Imaging 
Neuroimaging has had a crucial role in AD studies for the past four decades with different 
modalities such as computed tomography or MRI. More recently, structural and functional MRI 
showed significant changes in the brains of AD patients. No single neuroimaging modality can 
produce every possible image of other neuroimaging techniques, but they all have their uses 
and weaknesses. With AD, it is not always clear to make a clinical diagnosis without the use of 
neuroimaging; for a definitive diagnosis, neuroimaging is needed (Smitha et al., 2017). 
 In terms of structural imaging, MRI can detect progressing atrophy (volume), and the 
brains of AD patients can have vascular damage that will alter incoming MRI signals for the 
T2 images for some sequences. Progression of AD can be identified by checking cerebral 
atrophy in the brain, which starts early in AD. Atrophy first manifests itself in the medial 
temporal lobe, which is the first sign of AD. Because of this, atrophy of the medial temporal 
lobe is considered to be one of the biomarkers in AD that can be detected with structural MRI 
(Johnson et al., 2012, Smitha et al., 2017). 
 In terms of functional imaging, fMRI is a fairly new method when compared to 
structural MRI. Brain networks related with memory and other cognitive functions of AD 
patients are getting increasingly investigated with fMRI. Both task-fMRI and rs-fMRI give 
information about functional connectivity within the brain networks of an AD patient and can 
be useful in early detection of AD. Although fMRI has potential for this, a relatively smaller 
number of studies are published that are made with AD patients. There are some studies that 
reported a decrease in the medial temporal lobe in patients with mild cognitive impairment 
(MCI). Recently there is some increase on studies with BOLD fMRI techniques and 
spontaneous brain activity with rs-fMRI on AD patients. Especially in terms of pharmacology, 
fMRI might be the best way to monitor cognitive function in AD patients. Furthermore, 





focus is on characterization of vascular and metabolic features in brains of patients with AD 
(Lajoie et al., 2017, Johnson et al., 2012, Smitha et al., 2017). 
 
2.1.5 Limitations of fMRI 
The temporal resolution in fMRI, which can be achieved by the high scanning speed of the 
modality, needs larger voxel sizes to maintain the required level of signal to noise ratio (SNR). 
For this reason, fMRI has increased temporal resolution and decreased spatial resolution from 
the generated images. The limit for temporal resolution in fMRI is set by the BOLD signal. As 
it is not possible to increase the speed of neuronal responses, and BOLD signals are generated 
from the neuronal responses, maximum temporal resolution is dependent on the BOLD signal 
(Huettel et al., 2014, Poldrack et al., 2011).  
One of the significant challenges of fMRI is head motion during the scan. Patients often 
move during scanning, and in most cases the patient’s head motion during the scan cannot be 
avoided. This issue would be a huge problem since AD patients might have conditions that may 
make them less compliant, such as mood swings or short-term memory problems. Because of 
the compliance issues, head motion effects would be problematic for both rs-fMRI and task-
fMRI. However, there are methods to be used during the scan and algorithms in pre-processing 
steps that can eliminate the effects of head motion. In some cases, head motion can be corrected 
for after pre-processing fMRI images, allowing further analysis to be performed (Huettel et al., 
2014, Poldrack et al., 2011).  
In fMRI, like PET, patients with claustrophobia may face challenges, since fMRI 
imaging requires patients to be in a tight and enclosed space during the scanning time. fMRI is 
based on magnetic force, so patients with metal implants or some metal-based tattoos cannot 
be scanned with fMRI, thereby presenting an additional limitation to the use of fMRI as a 





2018). Lately, there are productions of MRI compatible pacemakers that will enable patients 
with these pacemakers to be allowed for fMRI scans. Also, patients with obesity may not be 
compatible for fMRI if their measurements are more than what the machine can handle (Huettel 
et al., 2014, Poldrack et al., 2011).  
Lastly, the scan time is another factor that limits fMRI studies. Generally, a fMRI scan 
takes between 2-12 minutes. Individual time points are not independent in terms of statistics in 
BOLD signals. Since they are not statistically independent for each fMRI scan, the correlation 
value must be corrected for degrees of freedom to determine significance. In short scans, 
estimating significance becomes problematic because of a low number of time points available. 
To fix this issue, scanning time higher than 5 minutes is needed to allow detection of most 
studied networks such as the default mode network. Furthermore, increasing the time decreases 
the noise and increases the correlation strength, but may not be necessary. Increasing the 
scanning time might cause more head motion or discomfort to the patient so the optimal 
scanning time of 5-6 minutes appears to be sufficient for most studies (Van Dijk et al., 2010). 
 
2.2 Data Acquisition 
This study was performed on a public dataset from “Alzheimer’s Disease Neuroimaging 
Initiative” (http://adni.loni.usc.edu/). MRI and fMRI techniques were used to acquire 
anatomical and functional images for each subject. The subjects of this study included both 
healthy controls and patients with Alzheimer’s disease. T1-weighted images were acquired 
using both 1.5T and 3T MRI scanners at different sites and the spatial resolutions of the 
anatomical images were 1x1x1.2 mm3. All fMRI images were acquired with 3T Philips MRI 
scanners. Parameters of fMRI scans: TR (repetition time) = 3000 ms, TE (echo time) = 30 ms, 
flip angle = 80o, matrix = 64 x 64, slices =15 and, voxel size = 3.3125x3.3125x3.313 mm3. 





fMRI scans date-time of the scan, age of the subject, condition of the subject (Healthy Control 
or Alzheimer’s disease patient), and sex information were available this dataset. As reflected in 


































In this section, the pre-processing methods are described with a focus on the methods used in 
the current study. Additionally, the definitions of each of these processes and the importance of 
these functions are presented. fMRI applies a series of set algorithms on the obtained dataset. 
In this model, it is often necessary to eliminate white noise in the data to improve the signal to 
noise ratio. The process of eliminating noise and unnecessary data from CSF and large 
ventricles is regarded as pre-processing. Also, the fMRI data is transformed to a standardized 
space to make the comparison between 2 or more brain scans possible. The pre-processing 
pipeline may differ for each study but is generally initiated with the realignment of the 
functional images.  
During this phase, additional steps are often needed before realignment depending on 
the dataset. These can include reorienting functional and anatomical images. The pre-
processing pipeline of realignment, coregistration, segmentation, normalization, temporal 
regression, and filtration is applied across all the subjects within the dataset. To increase the 
efficiency of pre-processing, scripts are provided in standard software programs, which can be 
run in a batch from the Statistical Parametric Mapping software SPM12 (Friston et al., 1994) 
in MATLAB (Higham & Higham, 2016). AFNI (Cox, 1996) and MATLAB were used in this 
study for both pre-processing and data analysis. To provide a more comprehensive review of 
pre-processing, the following sections will discuss the individual steps.  
 
Pre-processing steps. In this section, the steps taken before statistical analysis is presented. 
Pre-processing is applied to make sure all the data is in the same orientation, corrected for head 





analysis. These steps are required to achieve statistically significant results. In this study, the 
pre-processing is carried out as follows: 
1. Realignment of functional images, 
2. Coregistration of functional images to anatomical images, 
3. Segmentation of the anatomical images, 
4. Normalization of functional images to the MNI space from subject space, 
5. Creation of tissue masks from segmented files of anatomical images, 
6. Extraction of information from white matter (WM) and cerebral spinal fluid (CSF), 
7. Temporal regression using motion parameters and information form WM and CSF, and 
8. Bandpass filtration of signals to 0.01 – 0.1 Hz band. 
 
 
Figure 3.1 Raw fMRI image of an anonymous subject from the current study in the native space 






The first step of pre-processing is realignment. Realignment step is standard step for fMRI 
images to minimize the effects of head motion. This process is necessary as it is not possible to 
ensure complete stillness during the scanning process. However, patient movement can produce 
false-positive results within the fMRI data of that subject. Realignment attempts to align all the 
time points in a fMRI time series. This is necessary because some of the time points in an image 





could be any of the time points within a functional scan or the mean of all the time points within 
a scan (Hafiz, 2017).  Thus, all the images must align with each other to ensure all errors are 
corrected for in the final analysis (Friston et al., 1996, Poldrack et al., 2011).  
For this process, the motion correction algorithm uses a least-squares method with a six-
parameter rigid body transformation (Friston et al., 1995) representing three rotational (pitch, 
roll, yaw) and three translation (x, y, z) parameters. In realignment, a file with information on 
these six parameters is generated to further minimize any motion-related artifacts (Hafiz, 2017). 
After realignment, the images are resliced such that they match the first image selected voxel-
for-voxel to deal with signal discrepancies before normalization. The realignment for this study 
has been performed using SPM12. 
 






The coregistration process consists of aligning and overlaying the fMRI data on the anatomical 
image. To be able to use these images together, they need to have the same coordination with 
each other. Coregistration is used to align the head-motion-corrected fMRI images towards the 





words, the corrected images are aligned with the anatomical image to allow for an accurate 
spatial fit.  
The main reason for registering fMRI images to anatomical images is to allow SPM12 
to identify the regions of the brain since anatomical images have much better spatial resolution. 
Furthermore, the high-resolution quality of anatomical images increases efficacy for assessing 
brain locations of fMRI scans of each brain. Through coregistration, viewing the functional 
information regarding the brain is improved due to the correlation with anatomical and high-



















After coregistration is complete, the next step in the pre-processing pipeline is segmentation. 
Segmentation is the process that partitions the anatomical (or functional) image into different 
tissue classes. Segmentation is critical due to the integral human brain anatomy. The human 
brain is classified within three different tissue types, (1) gray matter (GM), (2) white matter 
(WM), and (3) cerebrospinal fluid (CSF). Thus, segmentation is critical to ensure that the 
anatomical skull categorizes the separation of the brain tissue. Each anatomical brain image is 
used for each patient. Figures 3.4 and 3.5 illustrate the process of segmentation for this study.  
 In this process, intensity differences in the anatomical MRI images are used. When using 
SPM12, a series of 6 differing tissue types are generated. These tissues are GM, WM, CSF, 
skull, soft tissue, and remaining parts of the scan (the outside region). It is also essential to 
consider the bias information. In this model, bias field estimation and correction is the 
normalization of values for different tissue types in the brain. Correction for the 
inhomogeneities dramatically increases the accuracy of the segmentation process. SPM12 does 
all of this in a single step. WM and CSF tissue classes are used to generate masks for further 













Figure 3.4 White matter output of segmentation of a single anatomical scan from the study in 






Figure 3.5 Cerebral spinal fluid output of segmentation of a single anatomical scan from the 













The process of normalization includes transforming every image into a generic template, such 
as the MNI template, that can be applied to all fMRI images. In this process, images from each 
of the subjects are transformed into a standardized space so that all images for every subject 
will have the same coordinate system and can be processed for statistical analysis. This step is 
vital for group-level analysis. As mentioned earlier, all functional images are in their 
native space, and every native space is different from that of other native spaces. Thus, each 
patient's brain size and shapes are different, and it is necessary to ensure that these different 
shapes are in a normalized space for future analysis. For batched or group-level analysis, images 
must be in a standard space. The process of normalization warps each patient's brain size and 
shape into a standardized brain model that ensures that the spatial fit of all brains are the same. 
Thus, the coordinates for comparison between brains is possible through this process of 
normalization. The most common standardized space templates are the Montreal Neurological 
Institute (MNI) space and the Talairach Space.    
For this study, the MNI152 space was used for transformation  (figure 3.6). The MNI152 
template was created from 152 brain scans of a young adult. SPM12 requires both anatomical 
images and fMRI images of each patient to perform transformation of images from native space 











Figure 3.6 Differences between outputs after coregistration (top) and normalization (bottom) 
of a single scan from the study into MNI space. 
  
3.5 Nuisance Regression and Temporal Filtering 
For this study, PCA was used for assessing correlated components within the fMRI data to 
perform nuisance regression. PCA also assesses voxels synced with each other in specific 
regions within the fMRI data. Thus, the principal components or eigenvectors (e.g., a value 
different than zero) of the covariance matrix of the fMRI data was identified. After the 
normalization step in the pre-processing pipeline, WM and CSF images from segmentation are 
used to create masks. The masks were generated using 0.98 threshold values of the segmented 
images of WM and CSF and resampled to the voxel size of the functional images. A PCA of 
5th degree was run on the fMRI data using the respective WM and CSF mask for each individual 
subject. Doing this allowed synced voxels within WM and CSF in the brain regions to be 
gathered in a single covariance matrix. These generated values include data from the WM and 
CSF regions, and since the point of interest is the data from GM, linear regression of these 





of the effects of WM and CSF that we would see from the group analysis of the data. PCA had 
been done on the functional scans with MATLAB to be used in the temporal regression step 
(Hafiz, 2017).  
 As noted, regression is used to get rid of effects from WM and CSF. Furthermore, 
motion parameters from the realignment step were also regressed out from the fMRI scans. 
Both extracted values from PCA and 24 motion parameters (six motion parameters, derivatives 
of each motion parameter, forward derivatives of each motion parameter, as well as squared 
forward derivatives of each motion parameter) were used in the regression step. In other words, 
a total of 34 regressors were used in the regression step. To regress out these 34 regressors from 
the fMRI scans, MATLAB was used. First, ten time-points of the time series of the fMRI scans 
were removed to avoid false-positive results, which can be caused by the scanning process's 
adaptation period at the start of the procedure (Azeez & Biswal, 2017, Hafiz, 2017). After 
temporal regression, a bandpass temporal filter in the range of 0.01-0.1Hz was applied to all 
time series, to remove any physiological noise and other artifacts using AFNI. This is a standard 












Figure 3.7 Signal differences in the hippocampus between normalized fMRI image (top 9 





For the last step of pre-processing, spatial smoothing was used to increase the signal to noise to 
noise ratio. A 6mm full width at half maximum (FWHM) filter was used for smoothing. The 6 
mm FWHM was used because the voxel size of the normalized fMRI images was 3mm. For 
best results, twice the voxel size number of the fMRI image must be used as the FWHM value. 
Also, for certain data sets with enough samples, it is crucial to use a minimum FWHM value 








Figure 3.8 Differences between outputs after filtration (top) and smoothing (bottom) of a 























FUNCTIONAL CONNECTIVITY AND STATISTICAL ANALYSIS 
 
Functional connectivity is the temporal correlation of 2 or more neurophysiological signals at 
spatially different locations in the brain. These events can be analyzed either in the time or 
frequency domain. Temporal analysis can provide information about the changes within a given 
time series in an fMRI dataset. Frequency analysis can provide information about the frequency 
content of the events that are happening in a particular fMRI dataset. These techniques can also 
be designated into either a model-driven or a data-driven analysis. Each model can include 
either frequency analysis or temporal analysis methods. Model-driven methods are useful when 
there is some prior information about the current dataset and research topic, while data-based 
methods make no such assumptions and finds the areas of interest according to the fMRI data 
provided. In this study, data-driven methods are mostly used, and the only model-driven 
approach would be the three regions that were identified from the Independent Component 
Analysis (ICA) (Azeez & Biswal, 2017, Buckner et al., 2013, Chen et al., 2020, Friston, 1994). 
 
Table 4.1 Methods Used For This Study 
 
Methods Data-Driven 
Temporal ICA, ReHo 
Frequency ALFF, mALFF, fALFF 
 
 
After the completion of the various analyses, the results were inputted into a multiple 
linear regression model to find their significance in terms of P-values, as explained in section 







4.1 Temporal Domain Methods 
4.1.1 Independent Component Analysis (ICA) 
ICA is a popular data-driven method in neuroimaging.  ICA is a method like PCA with a crucial 
difference: while the PCA method estimates components that are orthogonal, ICA generates 
components that are independent of each other. PCA cannot accomplish this because it assumes 
a Gaussian distribution (Azeez, 2019, Azeez & Biswal, 2017, Hafiz, 2017).  With ICA, we 
obtain independent components for the fMRI images. This means that for the rs-fMRI data, we 
can see the resting state networks from the analysis. From the spatial maps, there is a challenge 
in linking these spatial maps to neurological function. It is also a way of confirming the quality 
of the data and preprocessing. Generally, after ICA for rs-fMRI data, there is a certain number 
of resting state networks that a researcher expects to see (Azeez & Biswal, 2017, Calhoun et 
al., 2003, Chen et al., 2008, Smitha et al., 2017). 
For this study, a group ICA was applied to the dataset after the pre-processing procedure. 
Group ICA was performed using the MELODIC feature from FSL (the FMRIB Software 
Library) (Jenkinson et al., 2012). Three sessions were made using 20, 25, and 30 component 
ICA. The reason for these choices was to achieve the best ICA components while avoiding a 
mixture of components to form (Beckmann et al., 2005). In the 20 component ICA, some resting 
state networks that needed to be separate were mixed into a single spatial map. With the 30 
component ICA, some resting state networks that needed to be a single spatial map were 
separated into multiple maps. The best results were acquired using a 25 components ICA. From 
the 25 component ICA analysis, 3 probability maps were used to create masks with the SPM12 
image calculator to be used in further steps of the analysis. For the masks, a threshold value of 







Figure 4.1 Resting state networks generated from group independent component analysis. 
A. aDMN (anterior default mode network), B. CN (cerebellar network), C. DA (dorsal 
attention), D. DMN (default mode network), E. dSM (dorsal sensory motor), F. FC (frontal 
cortical), G. LFP (left frontoparietal), H. LV (lateral visual), I. MT (medial temporal), J. MV 
(medial visual), K. RFP (right frontoparietal), L. VS (ventral stream), M. vSM (ventral 
sensory motor) (sagittal – coronal – axial view). 
 
 
4.1.2 Regional Homogeneity (ReHo) 
Regional Homogeneity, also known as ReHo, is another data-driven approach. This method 
applies a voxel by voxel approach to map underlying connectivity activations within the brain. 
As the name suggests, ReHo finds the average correlation with its neighboring voxels for every 





coefficient (KKC) is used in conjunction with the size of the clusters (Zang et al., 2004). ReHo 
is considered to be a robust method against noise but is still susceptible to signal artifacts and 
can cause false positive results. Local functional connectivity is the synchronized response of a 
BOLD time series for the functional activations in a given 10-15 mm region. Based on the 
hypothesis of significant brain function, these 27 voxels or 10-15 mm area are active in a form 
of cluster rather than a single voxel. (Azeez & Biswal, 2017, Bayram et al., 2018, He et al., 
2007, Jiang & Zuo, 2016, Liu et al., 2008).  
 In this study, the masks created from the probability maps acquired from group ICA 
analysis are used on the ReHo maps. The ReHo spatial maps are generated using AFNI. Outputs 
of temporal regression and filtration were used to generate ReHo spatial maps. Using the masks 
on the spatial maps, the mean value for each fMRI scan were calculated using MATLAB to be 
used later in multiple linear regression analysis (Di et al., 2019). Lastly, outputs of ReHo were 
smoothed using SPM12.  
  
 
Figure 4.2 Regional homogeneity of an anonymous subject from the current study overlaid on 









4.2 Frequency Domain Methods 
4.2.1 Amplitude of Low Frequency Fluctuations (ALFF) 
In rs-fMRI, functional connectivity is highly correlated with low frequency fluctuations. ALFF 
presumes that all neurological activity in a BOLD signal from rs-fMRI can be shown with a 
singular parameter. In short, it takes the square root of the power of BOLD signals in 0.01-0.1 
Hz range and sums it up to obtain the ALFF value. This method is sensitive to noise sources; 
hence, quality and preprocessing of the raw data plays an important role in ALFF. Because 
ALFF might have noisy signals, there will be a higher probability of a large ALFF value. An 
alternative method called fractional ALFF (fALFF) can also be used. In fALFF, the ALFF value 
is divided by the spectral power for the entire power spectrum. This method also may produce 
low quality spatial maps caused by low quality in fMRI scans, but it may produce significant 
results when provided with quality rs-fMRI scans (Zou et al., 2008). Another version is the 
global mean ALFF (mALFF). In mALFF, as the name suggests, each voxel in ALFF gets 
divided by the global mean of ALFF (Yang et al., 2019, Fox & Raichle, 2007). 
The masks created from the probability maps acquired from group ICA analysis are 
used on the ALFF, fALFF, and mALFF maps (figure 4.4). These spatial maps are generated 
using AFNI. Outputs of temporal regression were used to generate ReHo spatial maps. Using 
the masks on the spatial maps, the mean value of each fMRI scan and each spatial map were 
calculated using MATLAB to be later used in the multiple linear regression analysis (Di et al., 








Figure 4.3 ALFF (top), mALFF (middle), fALFF (bottom) of an anonymous subject from the 
current study overlaid on MNI template (Axial – Sagittal – Coronal view). 
 
4.3 Multiple Linear Regression Analysis 
In this study, all the spatial maps from ALFF, mALFF, fALFF, and ReHo are used with 3 masks 
generated from the probability maps from ICA to get individual mean values for specific 
regions. The regions used are the Default Mode Network (DMN), the Medial Visual Network 
(MV), and the Medial Temporal Network (MT). A value, or score, is generated for each spatial 
map and used within the multiple linear regression analysis. Other than the ALFF, fALFF, 









Figure 4.4 Formula used for multiple linear regression analysis. 
 
 
As can be seen from the formula (figure 4.5), both predictors X1 and X2 create a third predictor 
by multiplication. In other words, the third coefficient is influenced by the first two predictors. 
Even if the P value of one of the first two predictors is not significant, it may still be significant 
for the third feature. Similarly, if the first two features are significant, there is no guarantee that 
the third feature will be significant. This is called the hierarchical principle, and it basically 
means that two non-significant individual models could have significance when they interact. 
For this study, our predictors are age of the patients and the group they are in (HC or AD). 
 
4.4 Statistical Analysis of the Participants 
In the study, some subjects were removed due to several reasons. These reasons were: high 
motion that cannot be corrected, corrupted/missing rs-fMRI or anatomical images, and 
incompatible number of time points. Following the removal, the Shapiro-Wilk and Shapiro-
Francia Normality Test, the Levene’s Homogeneity Test, and a two-sample t-test had been 
performed for age. For gender, the Chi-squared test had been performed. In the study, there are 
61 individuals (33 are female and 28 are male). The age range of the participants is 56 to 91. 
The mean of these ages is 74.4721 and standard deviation is 7.0408 (figure 4.6). 
 The P value of the Shapiro-Wilk and Shapiro-Francia Normality Test was 0.6663, which 





which means homogeneity was met. The P value of the Two Sample T-Test was 0.1129, which 
means age should not affect the analysis. Similarly, the P value of the Chi-Square test was 
0.9061, which means gender should not affect the analysis. 
 
 
















This chapter will focus on the results obtained in this study. After preprocessing, there were 76 
scans for AD and 79 scans for HC, adding up to a total number of 155 scans used within the 
study. Voxel-wise functional connectivity parameters were obtained using several methods, 
including ICA, ReHo, ALFF, mALFF, and fALFF.  Spatial component maps were generated 
using ICA. Voxel wise parameters from each of the spatial maps were obtained using ReHo, 
ALFF, mALFF, and fALFF. Twelve different scores were generated from the dataset using the 
twelve plots made from the score, age, and category of the subjects. From the 12-score set, 6 of 
them (mALFF and ReHo) matched the results of previous studies, and the other 6 (ALFF and 
fALFF) were in low quality caused by low-quality scans (high head motion). Thus, spatial maps 
from ALFF and fALFF were not able to be used for further analysis. The six score sets that 
were acceptable were used to do a multiple linear regression analysis. For the analysis, every 
scan was presumed to be from a different subject even if several scans were taken from the 
same patient.  
 
5.1 Region of Interests 
After preprocessing, a group ICA was performed using data from all 155 individual scans. A 
total of 13 meaningful resting-state networks were determined from ICA, as shown in figure 
4.1 (Calhoun et al., 2003, Beckmann et al., 2005). From the probability maps generated with 
ICA, three maps were chosen to use as ROIs (figure 5.1). These ROIs were created by 
thresholding the probability maps. Selection of ROIs was done according to previously 





 In previous studies, it has been showed that the MT is one of the regions that gets 
affected from AD. Furthermore, it has been shown in functional brain imaging that these 
abnormalities occur before atrophy starts to present itself in the early stages of AD (Grajski & 
Bressler, 2019, Qi et al., 2018). The hippocampus in the MT is involved with memory, and 
memory loss is one of the major symptoms that AD patients suffer from. Subsystems which 
deal with memory are also linked to the DMN, which suggests that the FC of DMN also gets 
affected (Qi et al., 2018).  Because of this dilemma, it is expected to see decreased FC in the 
MT caused by the WM atrophy in AD patients (Berron et al., 2020), which is an easy symptom 
to miss in early stages of the disease with only a physical examination. The MT shows potential 
to be used as a neuroimaging biomarker for early detection of AD, which is also supported by 
metabolic abnormalities that can be seen within the network (Mevel et al., 2011, Greicius et al., 
2004, Ridha et al., 2007). 
 The DMN is a network that is connected to various regions within the brain and is one 
of the regions that has high potential to be used as a neuroimaging biomarker for early detection 
of AD (Badhwar et al., 2017). FC changes in the DMN are highly corelated with AD, especially 
in the precuneus (PCC) (Mevel et al., 2011). Connectivity between the PCC and hippocampus 
suggests that the DMN could also be a potential neuroimaging marker for early AD detection 
(Mevel et al., 2011). Although the DMN is a region that is highly used to separate HCs from 
AD patients, the diagnostic power of the DMN as a neuroimaging biomarker is yet to be seen 
because of high baseline FC of certain regions within the DMN (Koch et al., 2012). Past studies 
also show that though there were no statistical difference between HCs and mild cognitive 
impairment (MCI) patients, there were similarities at the PCC of the DMN (Wu et al., 2011, 
Yu et al., 2016). Furthermore, past studies show that MMSE values of AD patients seem to be 





power of DMN as a neuroimaging biomarker (Buckner et al., 2008, Sorg et al., 2007, Wu et al., 
2011). 
 Visual performance also decreases with AD, which suggests that the primary visual 
cortex could show FC differences in patients with the disorder (Armstrong,1996, Mendez et al., 
1990, Leuba & Kraftsik, 1994, Yamasaki et al., 2019). Nevertheless, there are some 
controversies about this, since only some clinical studies show visual performance differences 
between AD and MCI patients when compared with HCs (Armstrong, 2009). It is also important 
to consider any other conditions that may impact the patient’s eyesight before using visual 
performance as a parameter to differentiate HCs from AD and MCI patients. Since it is difficult 
to determine the primary reason for an impaired visual performance, FC differences between 
HCs and AD patients in the primary visual or the MV network can be a potential neuroimaging 
biomarker. Previous studies showed markers linked to AD were found not only within the 
primary visual cortex, but also on certain components of the eyes itself (Armstrong, 1996, 
Beach & McGeer, 1992, Ikonomovic et al., 2005, Kusne et al., 2017). While clinical tests show 
abnormalities in terms of visual function in both AD and MCI patients, there are not many rs-
fMRI and FC studies performed about this region (Cerquera-Jaramillo et al., 2018, Kusne et al., 
2017). Overall, the MV network shows potential to be a neuroimaging biomarker for AD, and 






Figure 5.1 ROIs created from probability maps acquired from ICA. DMN (top), MT (middle), 
MV (bottom) (axial – coronal – sagittal). 
 
5.2 Local Activity  
As mentioned earlier, three ROIs were used: DMN, MV, and MT. For each of the three resting 
state networks, we also generated mALFF and ReHo scores on a voxel-wise basis. By doing 
this, six scores were generated for each scan. These scores were: DMN-mALFF, DMN-ReHo, 
MT-mALFF, MT-ReHo, MV-mALFF, MV-ReHo. By using these scores as the y-axis and the 





to their groups (AD or HC). For each graph and each data point in the graphs, linear regression 
was used to determine the relationship between the two parameters in the graph. Scores were 
plotted as a function of age (Di et al., 2019). 
 
5.2.1 Local Activity Differences for DMN 
Figure 5.2 and Figure 5.3 show local activity differences in the DMN region from the mALFF 
and ReHo measures. In various studies, it has been shown that the DMN region has a role in 
AD (Mevel et al., 2011, Koch et al., 2012). The DMN has a major role in rs-fMRI studies and 
is a widely studied brain network in the neuroimaging world. The DMN is known to have high-
level metabolic activity during the passive state. This means that for rs-fMRI scans, the DMN 
should have high local and metabolic activity. Also, previous neuroimaging studies made with 
spontaneous low-frequency fluctuations and regional homogeneity show that it is linked to 
crucial subsystems (Sheline et al., 2010). It links various regions such as the precuneus 
cingulate cortex to these subsystems (Wang et al., 2006). Various studies show that impairment 
of DMN is a result of AD (Bayram et al., 2018, Marchitelli et al., 2018, Qi et al., 2018). 
As can be seen from Figure 5.2 and Figure 5.3, AD patients show decreased local 
activity for mALFF and ReHo measures within the DMN region for the dataset used in this 
study. From Figure 5.2 and Figure 5.3, we can also see that age has a decreasing effect in the 
DMN-mALFF and DMN-ReHo scores. By using the formula from Figure 4.4, a hierarchical 
model was used to perform a multiple linear regression analysis to see the effect of age and 
condition on the DMN-mALFF and DMN-ReHo scores. The purpose of this longitudinal 
analysis is to determine if the decrease in local activity or functional connectivity is different 







Figure 5.2 DMN-mALFF graph. 
 
Table 5.1 P Values From DMN Of mALFF Graph 
P-value of AGE feature 0.000000328 
P-value of GROUP feature 0.0377* 
P-value of AGExGROUP feature 0.1168 
 
Figure 5.2 illustrates a negative relationship between the dependent variable (mALFF) and the 
independent variable (age). The attained P values display a decrease in the dependent variable 
and an increase in the independent variable. Therefore, the P-value highlights that age is not a 







Figure 5.3 DMN-ReHo graph. 
 
Table 5.2 P Values From DMN Of ReHo Graph 
P-value of AGE feature 0.00182* 
P-value of GROUP feature 0.41757 
P-value of AGExGROUP feature 0.73272   
 
In comparison, Figure 5.3 justifies that the DMN-ReHo graph displays a negative relationship 
between the variables. However, the results attained were not significant, as the P-values did 
not exceed 0.05 for the last two features (Table 5.2). As highlighted before, the DMN includes 
the following regions within its boundaries: the posterior cingulate cortex (PCC) or precuneus, 
the ventral and dorsal medial prefrontal, the medial temporal lobes, and the lateral parietal 
cortices. Furthermore, the posterior cingulate cortex and the hippocampus is impaired in AD in 





of brain disconnections that further worsen the progression of AD on the patient. Furthermore, 
when age is factored in as a variable utilizing the two-sample T-test, a 0.1129 P-value affirmed 
that age would not affect the linear regression analysis results.    
 
5.2.2 Local Activity Differences for MT Lobe 
Figure 5.4 and Figure 5.5 show local activity differences in the MT region from mALFF and 
ReHo measures. Previous studies showed that the MT is affected in the brains of AD patients. 
The MT lobe includes the hippocampus and has a vital role in terms of memory. The MT is 
responsible for several cognitive and emotional functions. Atrophy of the MT lobe is a common 
finding in many studies (Ridha et al., 2007). Furthermore, many PET studies also show that 
metabolic activity also differs between HCs and AD patients for the MT lobe (Fischer et al., 
2019, Mevel et al., 2011, Márquez & Yassa, 2019). This suggests that regional brain atrophy 
of the MT lobe has a role in the corresponding resting state activity, and AD patients present 
symptoms like verbal memory decline, episodic memory decline, visual memory decline, 
memory recall delay increase etc. (Mevel et al., 2011, Gilboa et al., 2015, Yamashita et al., 
2019). Also mentioned above, the MT lobe is a subsystem of DMN, which means a local 
activation decrease at DMN would also show itself in a local activity decrease at the MT lobe. 
In other words, sub-regions of the MT lobe that deals with memory are major locations that get 
affected in AD patients. Since MT is a subsystem of DMN, it is logical to presume memory 
decline and decreased local resting activity in DMN means a decreased local activity for the 
MT lobe (Bayram et al., 2018, Berron et al., 2020, Liu et al., 2008, Rombouts et al., 2005). 
          As can be seen from Figure 5.4 and Figure 5.5, AD patients show decreased local activity 
for mALFF and ReHo measures within the MT lobe region for the dataset used in this study. 
However, from Figure 5.4 and Figure 5.5, we can also see that age has a decreasing effect in 





Using the formula from Figure 4.4, a hierarchical model is used to do a multiple linear 




Figure 5.4 MT-mALFF graph. 
 
Table 5.3 P Values From MT Of mALFF Graph 
P-value of AGE feature 0.0733 
P-value of GROUP feature 0.1530     









Figure 5.5 MT-ReHo graph. 
 
Table 5.4 P Values From MT Of ReHo Graph 
P-value of AGE feature 0.473     
P-value of GROUP feature 0.903     
P-value of AGExGROUP feature 0.1566     
 
Figure 5.4 illustrates the relationships between the MT and mALFF, where the dependent 
variable was the mALFF of MT while the independent variable was age. In contrast, for the AD 
results, the line projects a negative relationship in which when the y-variable increases, the age 
variable correlates towards the reduction plane for AD.  The P values prove significant in the 
context of AD and HC groups, respectively. Studies support that frontotemporal dementia in 





al., 2010, Rombouts et al., 2005, Smitha et al., 2017,  Yetkin et al., 2006). In Figure 5.4 and 
Figure 5.5, the P-value hardly meets a 0.05 threshold to be significant (Table 5.3 & Table 5.4).  
To check for the correlation between the voxels, Kendall’s correlation coefficient 
(KKC) is used. The size of the clusters that are found is around 27 voxels. The method is used 
to describe local functional connectivity at a given voxel and its neighboring voxels. Local 
functional connectivity refers to the synchronized response of the BOLD time series for 
functional activations in each 10-15 mm region. Based on the hypothesis of significant brain 
function, these 27 voxels, or 10-15 mm area, happen in the form of a cluster rather than a single 
voxel. Figure 5.4 and 5.5 illustrate that in the MT during early AD, FC of the hippocampus 
decreases according to HCs.  
 
5.2.3 Local Activity Differences for Primary Visual Network 
Figure 5.6 and Figure 5.7 show local activity differences in the MV region from the mALFF 
and ReHo measures. Unlike the DMN or MT lobe, the visual cortex has not been as widely 
studied in AD patients within the neuroimaging world. It is known that AD also affects the 
visual system. Although AD is mostly known to affect cognitive function, there are also known 
effects on various sensory functions, such as the visual systems. Visual dysfunctions in AD are 
possible neuroimaging biomarkers at the functional level. Nevertheless, there are fairly few 
neuroimaging studies done on the visual cortex in AD. AD is known to cause reduced retinal 
thickness, retinal vasculature, and quantity of optic nerve axons. Furthermore, visual problems 
show themselves in early AD. Some of these are visual acuity, contrast sensitivity, color 
discrimination, visual-special perception, the processing speed of visual information, and 
visual-spatial attention. Because of all these dysfunctions, it is possible and logical that AD 





(Armstrong, 2009, Cerquera-Jaramillo et al., 2018, Kusne et al., 2017, Leuba & Kraftsik, 1994, 
Zhang et al., 2009). 
          As can be seen from Figures 5.6 and 5.7, AD patients show decreased local activity for 
mALFF and ReHo measures within the MV lobe region for the dataset used in this study. From 
Figure 5.6 and Figure 5.7, we can also see that age has a decreasing effect in MV-mALFF and 
MV-ReHo scores, just like in the DMN-mALFF, DMN-ReHo, MT-mALFF, and MT-ReHo 
scores. Using the formula from Figure 4.4, a Hierarchical model is used to do a multiple linear 












Table 5.5 P Values From MV Of mALFF Graph 
P-value of AGE feature 0.00000162 * 
P-value of GROUP feature 0.0615 
P-value of AGExGROUP feature 0.1191 
 
To investigate brain activity in people with impaired cognitive activity, changes concerning the 
brain structure as well as function are of vital concern. Figure 5.6 did not meet a 0.05 threshold 
for the last two features (Table 5.5). This implies that the (P<0.0615) value is insignificant.  
 
 








Table 5.6 P Values From MV Of ReHo Graph 
P-value of AGE feature 0.00241* 
P-value of GROUP feature 0.41471 
P-value of AGExGROUP feature 0.56839   
 
ReHo or mALFF of BOLD signals, as delineated in Figure 5.6 and Figure 5.7, have assessed 
changes in the resting state occipital cortex of this study’s respondents. Both effects could exist 
together in either MCI of AD. The diminished FC in the cuneus/precuneus was considered to 
be related to decreased memory execution, and the expanded action could be paying for harm 
by the enlistment of different regions such as MV. It is also a known that AD affects atrophy in 
WM, which includes visual mechanisms that can cause FC changes in GM at MV. Nevertheless, 



















DISCUSSION AND CONCLUSION  
 
The current study investigated rs-fMRI scans of AD patients and healthy controls to identify 
differences between the two groups. Spatial maps, generated from the rs-fMRI scans of the AD 
patients and the HCs and analyzed using several multiple linear regressions, were used to 
compare the two groups in a longitudinal approach. The discussion section further examines 
the outcomes of this functional connectivity analysis. 
 
6.1 Discussion 
This study, although unable to show statistically significant results with the AGExGROUP 
feature of the equation, does show expected local activity differences between HCs and AD 
patients as a function of age in the patterns within the graphs. The purpose of this study was to 
measure local activity differences with a ROI-based hypothesis using the Hierarchical Principle 
with rs-fMRI scans. In further studies with a similar approach, and with a more controlled 
(stages of the disease) and more quality dataset, it is possible to generate statistically significant 
results. The importance of this approach is to be able to identify biomarkers for AD to be used 
in popular methods such as machine learning and graph theory (Huf et al., 2014, Khazaee et al., 
2015). In other words, finding potential neuroimaging biomarkers from a detailed and high-
quantity rs-fMRI AD dataset has potential to be used as diagnostic tools on future patients to 
start their treatment as soon as possible. This would help with the diagnosis of the disease, since 
it is expected that the number of AD patients will drastically rise in the future. In AD, early 
detection and diagnosis of the disorder are generally not easy to make, and late treatment loses 
its effectiveness. Furthermore, early symptoms are easy to mix with those of becoming elderly. 






6.1.1 Functional Connectivity (FC) 
To begin, the standard longitudinal analysis failed to produce any significant outcomes in this 
study. In the current study, the graph displays significance in the DMN and the MV, which 
impacts the age variable inversely instead. In contrast, the inter-network functional activity 
evolves with age, and the anti-correlated activity between the dorsal attention network and the 
DMN also significantly minimizes with age. Past research indicated that reduced FC raised the 
hypothesis that cortical hubs, including PCC, are susceptible to functional deterioration as a 
result of their relatively high metabolism (Qi et al., 2018), which is no longer maintained due 
to amyloid deposition that co-occurs in these hubs (Berron et al., 2020). Despite the consistency 
with the literature of the observed FC outcomes pointing out lower connectivity in AD, the 
research findings did not indicate reductions in the DMN network that were statistically 
significant on a robust level. Some of the main reasons for this could be because: a limited 
number of scans since data-driven methods function better with more data; a limited amount of 
information about the scans could suggest the possibility that the progression of the disease 
might be quite different for each patient; and the quality of the dataset that might have caused 
false negative results. 
 
6.1.2 Impairment of DMN is a Result of AD 
The results of the mALFF of the DMN indicated that AD patients show decreased local activity 
for mALFF as well as ReHo measures within the DMN region for the dataset included in this 
study. The relationship between localized neural activity and dynamic connectivity in the two 
core regions of the DMN was identified through directionally asymmetric and particularly 
specific ROIs: DMN, MV, and MT. AD patients showed decreased local activity for mALFF 





However, further analysis indicates that age has a considerable impact, since it has a reducing 
impact in MV-mALFF (Page-MV-mALFF =0.00000162) and MV-ReHo (Page- MV-ReHo = 0.00241) 
scores similar to the DMN-mALFF (Page-DMN-mALFF = 0.000000328), DMN-ReHo (Page-DMN-ReHo 
= 0.00182), MT-mALFF (Page-MT-mALFF = 0.0733), and MT-ReHo (Page-MT-ReHo = 0.473) scores. 
As can be seen from the P values in the multiple linear regression analysis of the graphs 
(Chapter 5), 4 out of 6 measures were significant for the age feature. Furthermore, group 
features of the DMN-mALFF also showed significance with a multiple linear regression 
analysis (Pgroup-DMN-mALFF = 0.00377). When investigating rs-fMRI scans of individuals with 
impaired brain cognitive activity from the study, a multiple linear regression analysis with the 
mALFF and ReHo of 3 ROIs did not show significance for the third feature of the equation 
(AGExGROUP). Hence, the p values (P>0.5) are statistically insignificant. Therefore, this 
study shows that the hypothesis was not achieved.  
 
6.1.3 DMN in AD Patients 
From the study, DMN activity among AD patients is consistent with those found using the PET 
measure of resting-state brain metabolism and this shows the significant involvement of the 
PCC region for examinations through rs-fMRI scans for AD (Mevel et al., 2011, Marchitelli et 
al., 2018). Increments in DMN connectivity or activity have likewise been accounted for in 
patients with MCI when contrasted with AD (Gardini et al., 2015, Zhang et al., 2012). Along 
these lines, amnestic mild cognitive impairment (aMCI) patients were described by (i) 
increments in DMN activity situated inside the PCC/precuneus, (pre)frontal, lateral parietal, as 
well as central temporal cortices and (ii) increments in FC between right parietal cortex and left 
insula (Ward et al., 2014). Moreover, in AD, resting state activity decreases were found to 
involve (i) DMN activity inside the PCC/precuneus, frontal, occipital, parietal, and (pre)frontal 





–  left frontoparietal cortices (Zhong et al., 2014). These outcomes point to the occurrence of 
possible compensatory forms rising in the beginning phases of the infection that are situated in 
a few DMN regions (Mevel et al., 2011).  
On the other hand, aMCI and AD patients with high cognitive reserves demonstrated 
higher movement in task-related brain zones and expanded deactivations inside the DMN 
(PCC/precuneus, front cingulate) contrasted with those with low intellectual reserves (Solé-
Padullés et al., 2009, Yamashita et al., 2019). This more prominent reallocation of handling 
assets from the DMN to cerebrum territories legitimately occupied with the test errand could 
reflect expanded redesign of useful compensatory assets in patients with high psychological 
reserves. To summarize, higher cognitive reserve capacities permit a more-with-less method of 
brain function in normal aging and makes up for neurotic procedures as they show up 
(Rombouts et al., 2005). 
One other objective of the current studies evaluating the impacts of AD on the DMN is 
to disentangle biomarkers that might be valuable for the early diagnosis of the disease. The 
interruption of the hippocampus or PCC availability could be a decent applicant, as it increases 
as the illness progresses. Lower deactivations inside the entire DMN, and particularly inside 
(average) parietal territories, were also seen as related to change from aMCI. Furthermore, Koch 
et al. proposed that the utilization of multivariate investigations joining proportions of the 
movement of explicit DMN zones to proportions of the interconnectivity between these locales 
improved the determination precision. Strikingly, utilizing this methodology, the infection 
design seen in patients with AD could be distinguished in a great extent from that of aMCI 
patients, recommending that such a mix of resting state scans might be appropriate to diagnose 
AD at an early stage.  
Past studies have given an enlarging backing to a preferential alteration of the parts of 





areas stays indistinct. As per Buckner et al., cortical center points might be mainly influenced 
in AD considering their persistent high standard movement and related metabolism, which may 
prompt expanded helplessness (quite to beta-amyloid testimony). This speculation is backed by 
studies demonstrating a connection between amyloid deposition and impaired DMN function 
in older individuals without dementia. Further multimodal examinations in all-risk subjects and 
AD patients are expected to be even more likely to comprehend this fascinating cover between 
the DMN and the dissemination of beta-amyloid testimony inside the brain (Sheline et al., 
2010).  
Considering that there are similar trends within the graphs and that there are some 
significant results for some of the outcomes of the P-values from the multiple linear regression 
analyses, it is possible to say that this study is a positive step to achieve desired results with the 
current hypothesis with further research. As pointed out earlier, the DMN contains the 
precuneus or PCC. The functional connectivity between the hippocampus (which is in the MT) 
and the PCC appeared to be impaired with AD. Following reduction in visual processing areas, 
AD patients starts exhibiting memory-induced alterations or decrease in resting state activation 
of MT (Golby et al., 2005). The hippocampal atrophy instituted episodic memory and functional 
perturbation impairment due to the disruption of the cingulum bundle (Agosta et al., 2012, Sorg 
et al., 2007, Wu et al., 2011, Yamasaki et al., 2019, Zhang et al., 2009). 
  
6.2 Conclusion 
The results from the current study, although like the results from previous studies, are 
statistically insignificant. In other words, none of the results were able to explain the graphs 
with the AGExGROUP feature, and only the DMN-mALFF results were able to explain the 
GROUP feature. 4 out of 6 measures (DMN-mALFF, DMN-ReHo, MV-mALFF, and MV-





 This does not necessarily mean these features cannot be used as biomarkers. There are 
multiple reasons why the feature with age and group interaction from the formula was not 
significant for the 6 graphs. One of the main reasons is the quality of the fMRI scans. After 
realignment, six motion parameters were used to calculate frame displacement values for all 
scans. A standard deviation value of 2 was used as a threshold after taking the Z scores of the 
motion parameters. Even with 2 as the standard deviation, more than half of the dataset was 
excluded because of the high motion within the scans. Furthermore, some subjects had 
corrupted fMRI and anatomical scans that had to be removed. Even with the low quality of the 
fMRI scans, expected patterns within the graphs were seen. 
 Total number of 28 scans had to be removed due to following reasons: corrupted 
fMRI/T1 scans, inconsistent number of time points in fMRI scans, too many head motion 
effects after calculating frame displacement using the 6 motion parameters, and normalization 
issues. After the removal of scans, there were a total of 31 HCs and 30 AD patients left after 
pre-processing, which had either had single or multiple scans for each subject (total number of 
79 scans for HC and 76 scans for AD patients). Because of the data's limitations, a presumption 
of accepting each scan as an individual subject was made, but not even this was enough to be 
able to generate significance with the equation in Figure 4.4. 
Also, the scans were acquired at different sites. This could have caused variability in the 
data. Each MRI scanner has a unique noise coming from its components, called the scanner 
noise. Like the effects from head motion, this can cause certain values within the scan to elevate 
and cause false negative results.  
Another reason could be the age range of the groups that might have cause insignificant 
results. Differences in the age ranges for each group might have affected the slopes of the 
graphs, which might have created insignificant results. For AD patients, this range is between 





pattern of the line generated by the multiple linear regression analysis, thus affecting the 
significance of the result. 
 The last reason for non-significant statistical results could be the absent information of 
the data. There was no information about the stage of the disease for each AD patient. This 
could have caused variability in the data. This can also be seen in the differences between scores 
for patients with the same age and condition, as shown in the generated graphs (Chapter 5). 
Overall, resting state functional magnetic resonance imaging as a neuroimaging method has 
great potential to increase diagnoses and prognoses of AD. Using the modality and various 
analyses techniques, it is possible to find neuroimaging biomarkers for not only AD, but also 
other cognitive disorders for early detection. Although there is great potential, future research 
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